Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKinsey
Queensland Health
UBS
Moodys
Medtronic
Daiichi Sankyo
Merck
Cipla

Generated: October 20, 2017

DrugPatentWatch Database Preview

Ketorolac tromethamine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ketorolac tromethamine and what is the scope of ketorolac tromethamine freedom to operate?

Ketorolac tromethamine
is the generic ingredient in eight branded drugs marketed by Cycle Pharms Ltd, Allergan, Apotex Inc, Hospira, Amphastar Pharm, Gland Pharma Ltd, Sun Pharma Global, Alcon Pharms Ltd, West-ward Pharms Int, Bedford, Baxter Hlthcare Corp, Akorn, Fresenius Kabi Usa, Wockhardt, Luitpold, Roche Palo, Apothecon, Teva, Mylan Labs Ltd, Watson Labs, Mylan, Sagent Pharms, Sandoz Inc, Egalet Us Inc, Pliva, and Omeros, and is included in forty-seven NDAs. There are nineteen patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Ketorolac tromethamine has sixty-nine patent family members in twenty-three countries and six supplementary protection certificates in six countries.

There are eighteen drug master file entries for ketorolac tromethamine. Fifty-four suppliers are listed for this compound.

Summary for Generic Name: ketorolac tromethamine

US Patents:19
Tradenames:8
Applicants:26
NDAs:47
Drug Master File Entries: see list18
Suppliers / Packagers: see list54
Bulk Api Vendors: see list104
Clinical Trials: see list285
Patent Applications: see list6,972
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ketorolac tromethamine at DailyMed

Pharmacology for Ingredient: ketorolac tromethamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
KETOROLAC TROMETHAMINE
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC090017-001Nov 5, 2009ATRXNoNo► Subscribe► Subscribe► Subscribe
Apothecon
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION075348-001Nov 28, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION078737-001Oct 6, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
KETOROLAC TROMETHAMINE
ketorolac tromethamine
TABLET;ORAL074955-001Sep 19, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
TORADOL
ketorolac tromethamine
INJECTABLE;INJECTION019698-001Nov 30, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Allergan
ACULAR PRESERVATIVE FREE
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC020811-001Nov 3, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION074802-002Jun 5, 1997APRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION078299-001Jul 16, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
Amphastar Pharm
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION076209-002Jul 21, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
KETOROLAC TROMETHAMINE
ketorolac tromethamine
INJECTABLE;INJECTION091065-001Nov 27, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ketorolac tromethamine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan
ACULAR LS
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC021528-001May 30, 2003► Subscribe► Subscribe
Roche Palo
TORADOL
ketorolac tromethamine
TABLET;ORAL019645-001Dec 20, 1991► Subscribe► Subscribe
Allergan
ACULAR
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC019700-001Nov 9, 1992► Subscribe► Subscribe
Egalet Us Inc
SPRIX
ketorolac tromethamine
SPRAY, METERED;NASAL022382-001May 14, 2010► Subscribe► Subscribe
Allergan
ACULAR
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC019700-001Nov 9, 1992► Subscribe► Subscribe
Allergan
ACULAR PRESERVATIVE FREE
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC020811-001Nov 3, 1997► Subscribe► Subscribe
Allergan
ACULAR
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC019700-001Nov 9, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: ketorolac tromethamine

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,267,827Therapeutic compositions for intranasal administration which include KETOROLAC► Subscribe
7,476,689Therapeutic compositions for intranasal administration which include KETOROLAC► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ketorolac tromethamine

Country Document Number Estimated Expiration
Australia2009202969► Subscribe
Japan5735968► Subscribe
Spain2382509► Subscribe
South Korea20120058588► Subscribe
Denmark1654002► Subscribe
Japan3586735► Subscribe
Spain2082288► Subscribe
European Patent Office1654002► Subscribe
Canada2967362► Subscribe
ItalyMI912024► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: KETOROLAC TROMETHAMINE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00072Denmark► SubscribePRODUCT NAME: OKULAER SKYLLEVAESKE OMFATTENDE PHENYLEPHRIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER HYDROCHLORID OG KETOROLAC ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER KETOROLACTROMETAMOL; REG. NO/DATE: EU/1/15/1018 20150730
0784Netherlands► SubscribePRODUCT NAME: EEN OCULAIRE OPLOSSING WELKE FENYLEFRINE BEVAT, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN, ALSMEDE KETOROLAC, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/15/1018 20150730
2015000111Germany► SubscribePRODUCT NAME: OKULARE IRRIGATIONSLOESUNG, WELCHE PHENYLEPHRIN ODER DESSEN PHARMAZEUTISCH WIRKSAMES SALZ UND KETOROLAC ODER DESSEN PHARMAZEUTISCH WIRKSAMES SALZ UMFASST; REGISTRATION NO/DATE: EU/1/15/1018 20150728
C0090France► SubscribePRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728
923Luxembourg► SubscribePRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
/2015Austria► SubscribePRODUCT NAME: PHENYLEPHRIN, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND KETOROLAC, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1018 (MITTEILUNG) 20150730
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Medtronic
US Army
UBS
Citi
US Department of Justice
Fuji
AstraZeneca
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot